Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma
Cancer, 06/29/09
Anderson WF et al. - In a trial to discern the timing and/or age of exposure for cutaneous malignant melanomas (CMM), current results were consistent with a divergent and age-dependent solar hypothesis for CMM. Early-onset melanomas may represent gene-sun exposure interactions that occur early in life among susceptible individuals. Late-onset melanomas may reflect accumulated, lifelong sun exposure in comparatively less susceptible individuals.
Methods- Effect of aging on CMM incidence were systematically examined in data from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
- Standard descriptive epidemiology was supplemented with mathematical models.
- Impact of advancing age on CMM incidence was assessed by sex, histopathologic classification (superficial spreading melanoma [SSM] or lentigo maligna melanoma [LMM]), and anatomic site (face, head, and neck [FHN] or lower extremity [LE]).
- Sex, histopathology, and anatomic site were age-specific effect modifiers for CMM that indicated divergent (bimodal) early-onset and late-onset cancer pathways.
- Early-onset melanomas were associated predominantly with women, SSM, and LE.
- Late-onset melanomas were correlated with men, LMM, and FHN.
- Early- and late-onset melanoma populations were confirmed with age-period-cohort models that were adjusted for period and cohort effects.
- 2-component mixture models also fit the data better than a single cancer population.
Related Articles
Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma
Modern Pathology, 10/23/09
Relevance Score: 81%
Metastatic cutaneous malignant melanoma: Spectrum of imaging findings and the role of multimodality imaging
Journal of Medical Imaging and Radiation Oncology (JMIRO), 10/05/09
Relevance Score: 81%
Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 80%
Case of cutaneous malignant melanoma surviving 16 years with late recurrence
Journal of Dermatology, 11/04/09
Relevance Score: 79%
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09
Relevance Score: 69%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical excision of skin cancer: the importance of training
British Journal of Dermatology, 12/11/09
A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck
The Surgeon - Journal of the Royal College of Surgeons at Edinburgh and Ireland, 12/11/09
Importance of clear resection margins in anorectal malignant melanoma
British Journal of Surgery, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


